日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cys340Ser Mutation Abolishing S-Nitrosylation Drives GRK2 Mitochondrial Localization and Dysfunction

Cys340Ser突变导致S-亚硝基化丧失,进而驱动GRK2线粒体定位和功能障碍

Kayki Mutlu, Gizem; Kereliuk, Stephanie M; Hoteit, Maya; Chuprun, J Kurt; Mendes, Umur; Olgar, Yusuf; Koch, Walter J

Enteral olive oil supplementation as a rescue strategy for caloric insufficiency in critically ill neonates: a retrospective cohort study

肠内补充橄榄油作为危重新生儿热量不足的补救策略:一项回顾性队列研究

Aliyev, Ferid; Karatas, Ece; Yıldırım, Damla; Kayki, Gozdem; Yigit, Sule

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2024

药理学一年回顾:2024年美国食品药品监督管理局批准的新药

Aksoyalp, Zinnet Sevval; Kayki-Mutlu, Gizem; Wojnowski, Leszek; Michel, Martin C

Dexmedetomidine in neonates: utilisation trends and safety profile over time in a neonatal intensive care unit

右美托咪定在新生儿中的应用:新生儿重症监护病房的使用趋势和安全性随时间的变化

Kayki, Gozdem; Yalcin, Nadir; Celik, Hasan Tolga; Yigit, Sule

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023

药理学年回顾:2023年美国食品药品监督管理局批准的新药数量

Kayki-Mutlu, Gizem; Aksoyalp, Zinnet Sevval; Wojnowski, Leszek; Michel, Martin C

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022

药理学年回顾:2022年美国食品药品监督管理局批准的新药数量

Kayki-Mutlu, Gizem; Aksoyalp, Zinnet Sevval; Wojnowski, Leszek; Michel, Martin C

Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021

更正:药理学一年回顾:2021年美国食品药品监督管理局批准的新药

Kayki-Mutlu, Gizem; Aksoyalp, Zinnet Sevval; Wojnowski, Leszek; Michel, Martin C

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021

药理学一年回顾:2021年美国食品药品监督管理局批准的新药

Kayki-Mutlu, Gizem; Aksoyalp, Zinnet Sevval; Wojnowski, Leszek; Michel, Martin C

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020

药理学一年回顾:2020年美国食品药品监督管理局批准的新药

Kayki-Mutlu, Gizem; Michel, Martin C